Kathleen Wills is an associate in Sterne Kessler’s Trial and Appellate Practice Group. She concentrates her practice on complex patent litigation and has worked on cases involving pharmaceuticals and biotechnology products. Kathleen has provided valuable insight and support to TAG through all phases of litigation including trial. She also publishes in marketing and industry publications relating to Federal Circuit appellate decisions, PTAB strategy, and trademarks.
In addition, Kathleen works with Sterne Kessler’s Trademark & Brand Protection Practice on trademark enforcement.
While attending law school, Kathleen interned in the Office of Unfair Import Investigations at the U.S. International Trade Commission (ITC), the Chamber of Judge Horn at the U.S. Court of Federal Claims, and the Court of Federal Claim’s Office of Special Master Oler.
Kathleen served as President of George Mason’s Trial Advocacy Association and co-chaired the mentorship committee of the Pauline Newman IP American Inn of Court. She was also an active student pupil member of the Giles S. Rich Inn. Kathleen was an author for George Mason University’s Center for the Protection of Intellectual Property and continues to write for the Center for Intellectual Property x Innovation Policy (C-IP2). She has published various law articles, including those featured in the 337 Reporter: Paul J. Luckern Summer Associate Edition, Journal of the Patent and Trademark Office Society, Texas A&M Journal of Property Law, and Tulane Journal of Technology & Intellectual Property.
Before law school, Kathleen worked as a Protocol Coordinator at the National Institutes of Health where she also conducted neuroscience and clinical research in the Experimental Therapeutics & Pathophysiology Branch. Kathleen managed various imaging devices and protocols involving MRIs, MEGs, and EEGs, evaluated clinical scales for regulatory compliance, and ensured ethical patient reporting. She co-authored several papers regarding ketamine efficacy in Psychiatry Research: Neuroimaging, International Journal of Neuropsychopharmacology, and Journal of Affective Disorders.
Kathleen graduated magna cum laude with her B.S. in Neuroscience with a minor in forensic science from George Mason University’s Honors College.
- Privacy Law Considerations of AI and Big Data – In the U.S. & Abroad, George Mason’s Center for Intellectual Property x Innovation (2021)
- That Tattoo on Her Shoulder: The Intersection of Copyright Law & Tattoos, 7 Tex. A&M J. Prop. L. 4 (2021)
- The Tattoo That Sings: Soundwave Technology and Copyright Law, 23 TUL. J. Tech. & Intell. Prop. (2021)
- Patenting an Invention as a Free Black Man in the Nineteenth Century, 101 J. Pat. & Trademark Off. Soc’y 206 – SSRN’s 2020 Top Ten List for Innovation & Patent Law & Policy (2019)
- Amarin and Its Implications, 337 Reporter: Paul J. Luckern Summer Associate Edition (2019)
- Synaptic Potentiation and Rapid Antidepressant Response to Ketamine in Treatment-Resistant Major Depression: A Replication Study, Psychiatry Research: Neuroimaging (2018)
- Glutamatergic signaling drives ketamine-mediated response in depression: evidence from dynamic causal modeling, Int. J. of Neuropsychopharmacol. (2018)
- Anhedonia as a clinical correlate of suicidal thoughts in ketamine clinical trials, J. Affect. Disord. (2016)
Giles S. Rich American Inn of Court, Associate Member